Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Melanoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 22fludarabine phosphate 17Cyclosporine 15Peripheral Blood Stem Cell Transplantation 14Methotrexate 14Filgrastim 14Whole-Body Irradiation 11Mycophenolic Acid 11Busulfan 11Antilymphocyte Serum 11Radiotherapy 8Melphalan 8Exercise 8Dexamethasone 8Cytarabine 8Asparaginase 8venetoclax 7blinatumomab 7Vincristine 7Etoposide 7Daunorubicin 7fludarabine 6Methylprednisolone 6Mercaptopurine 6Granulocyte Colony-Stimulating Factor 6Therapeutics 5Psychiatric Rehabilitation 5Prednisone 4Immunotherapy, Adoptive 4Cord Blood Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Nurse Clinicians × Clear all
NCT00179764 2019-08-30

Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

Ann & Robert H Lurie Children's Hospital of Chicago

Phase NA Completed
68 enrolled
DermatologicLymphoidMyeloidOther hematologic neoplasm

Melanoma, Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡